Skip to main content

Advertisement

Log in

Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs

  • In Brief Report
  • Published:
Academic Psychiatry Aims and scope Submit manuscript

Abstract

Objective

Psychiatrists are well suited to provide office-based opioid treatment (OBOT), but the extent to which psychiatry residents are exposed to buprenorphine training and OBOT during residency remains unknown.

Methods

Psychiatry residency programs in the USA were recruited to complete a survey.

Results

Forty-one programs were included in the analysis for a response rate of 23.7 %. In total, 75.6 % of the programs currently offered buprenorphine waiver training and 78.1 % provided opportunities to treat opioid dependence with buprenorphine under supervision. Programs generally not only reported favorable beliefs about OBOT and buprenorphine waiver training but also reported numerous barriers.

Conclusions

The majority of psychiatry residency training programs responding to this survey offer buprenorphine waiver training and opportunities to treat opioid-dependent patients, but numerous barriers continue to be cited. More research is needed to understand the role residency training plays in impacting future practice of psychiatrists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13–4795. Rockville: Substance Abuse and Mental Health Services Administration; 2013.

    Google Scholar 

  2. Birnbaum HG, White AG, Reynolds JL, Greenberg PE, Zhang M, Vallow S, et al. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective. Clin J Pain. 2006;22(8):667–76.

    Article  PubMed  Google Scholar 

  3. Clark HW. Office-based practice and opioid-use disorders. N Engl J Med. 2003;349(10):928–30.

    Article  CAS  PubMed  Google Scholar 

  4. Thomas CP, Fullerton CA, Kim M, Montejano L, Lyman DR, Dougherty RH, et al. Medication-assisted treatment with buprenorphine: assessing the evidence. Psychiatr Serv Wash DC. 2014;65(2):158–70.

    Article  Google Scholar 

  5. Hasin D, Kilcoyne B. Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC. Curr Opin Psychiatry. 2012;25(3):165–71.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mark TL, Kassed CA, Vandivort-Warren R, Levit KR, Kranzler HR. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug Alcohol Depend. 2009;99(1–3):345–9.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Clark W. The state of buprenorphine treatment [Internet]. 2010 [cited 2012 Aug 30]; Buprenorphine in the treatment of opioid addiction: Reassessment 2010. Available from: http://buprenorphine.samhsa.gov/bwns/2010_presentations_pdf/01_Clark_508.pdf

  8. Tesema L, Bergeron G, Yeh J, Soliman M, Hathaway R, Pham C, et al. Auditing access to office-based therapy for opioid addiction in Massachusetts [Internet]. Abstract presented at the 141st American Public Health Association Annual Meeting and Exposition. Boston, MA; 2013. Available from: https://apha.confex.com/apha/141am/webprogram/Paper290933.html

  9. Thomas CP, Reif S, Haq S, Wallack SS, Hoyt A, Ritter GA. Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists. Psychiatr Serv Wash DC. 2008;59(8):909–16.

    Article  Google Scholar 

  10. West JC, Kosten TR, Wilk J, Svikis D, Triffleman E, Rae DS, et al. Challenges in increasing access to buprenorphine treatment for opiate addiction. Am J Addict Am Acad Psychiatr Alcohol Addict. 2004;13 Suppl 1:S8–16.

    Google Scholar 

  11. Suzuki J, Connery HS, Ellison TV, Renner JA. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency. Am J Addict. 2014.

  12. Van der Leeuw RM, Lombarts KMJMH, Arah OA, Heineman MJ. A systematic review of the effects of residency training on patient outcomes. BMC Med. 2012;10:65.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was funded in part by Harvard Medical School Eleanor and Miles Shore Fellowship Program for Scholars in Medicine (JS) and grants U10DA15831 from the National Institute of Drug Abuse (HC).

Disclosures

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joji Suzuki.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suzuki, J., Ellison, T.V., Connery, H.S. et al. Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs. Acad Psychiatry 40, 498–502 (2016). https://doi.org/10.1007/s40596-015-0313-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40596-015-0313-1

Keywords

Navigation